{"url_path":"/sec/grce/8-k/2026-06-05/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-05","source_url":"https://www.sec.gov/Archives/edgar/data/1444192/0001140361-26-024269-index.html","accession_number":"0001140361-26-024269","cik":"0001444192","ticker":"GRCE","issuer_name":"Grace Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1444192/0001140361-26-024269-index.html","primary_entity_key":"0001444192","primary_entity_name":"Grace Therapeutics, Inc."},"word_count":84,"has_tables":true,"body_markdown":"Item 9.01.\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits\n\nExhibit\n\n \n\nDescription\n\n[10.1](ef20075612_ex10-1.htm)\n\n \n\nConsulting Agreement by and between Carrie D’Andrea and the Company, dated June 5, 2026.\n\n104\n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\nSIGNATURES\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the\nundersigned hereunto duly authorized.\n\n \n\n \n\n \n\nGRACE THERAPEUTICS, INC.\n\n \n\n \n\n \n\n \n\nDate:\n\nJune 5, 2026\n\nBy:\n\n/s/ Prashant Kohli\n\n \n\n \n\n \n\nPrashant Kohli\n\n \n\n \n\n \n\nChief Executive Officer"}